作者:
G Justus,Hofmeyr [1]
;
Mandisa,Singata-Madliki [2]
;
Joanne,Batting [3]
;
Petrus,Steyn [3]
;
Katherine K,Thomas [4]
;
Rodal,Issema [5]
;
Ivana,Beesham [5]
;
Enough,Mbatsane [6]
;
Charles,Morrison [7]
;
Jen,Deese [8]
;
Jenni,Smit [9]
;
Neena,Philip [10]
;
Thesla,Palanee-Phillips [7]
;
Krishnaveni,Reddy [11]
;
Maricianah,Onono [6]
;
Timothy D,Mastro [12]
;
Jared M,Baeten [12]
;
Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium [13]
作者单位:
University of Botswana, Gaborone, Botswana.
[1]
Effective Care Research Unit, University of the Witwatersrand/Walter Sisulu University, East London, South Africa.
[2]
Effective Care Research Unit, University of Witwatersrand, University of Fort Hare, East London, South Africa.
[3]
UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Geneva, Switzerland.
[4]
Department of Global Health, University of Washington, Seattle, Washington, United States of America.
[5]
Department of Epidemiology, University of Washington, Seattle, Washington, United States of America.
[6]
Faculty of Health Sciences, Department of Obstetrics and Gynaecology, MatCH Research Unit (MRU), University of the Witwatersrand, Durban, South Africa.
[7]
Setshaba Research Centre, Pretoria, South Africa.
[8]
FHI 360, Durham, North Carolina, United States of America.
[9]
Pfizer Inc., Collegeville, Pennsylvania, United States of America.
[10]
Mailman School of Public Health, ICAP at Columbia University, New York, New York, United States of America.
[11]
Wits Reproductive Health and HIV Institute, School of Public Health, University of the Witwatersrand, Johannesburg, Gauteng, South Africa.
[12]
Kenya Medical Research Institute, Centre for Microbiology Research, Kisumu, Kenya.
[13]
Gilead Sciences, Foster City, California, United States of America.
[14]
DOI
10.1371/journal.pone.0299802
PMID
38722832
发布时间
2024-06-20